Aequus Pharmaceuticals Stock Market Value
| AQS Stock | CAD 0.01 0.01 50.00% |
| Symbol | Aequus |
Aequus Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Aequus Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Aequus Pharmaceuticals.
| 01/28/2025 |
| 02/27/2025 |
If you would invest 0.00 in Aequus Pharmaceuticals on January 28, 2025 and sell it all today you would earn a total of 0.00 from holding Aequus Pharmaceuticals or generate 0.0% return on investment in Aequus Pharmaceuticals over 30 days. Aequus Pharmaceuticals is related to or competes with NeutriSci International, and Bewhere Holdings. Aequus Pharmaceuticals Inc., a specialty pharmaceutical company, develops and commercializes drugs in Canada More
Aequus Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Aequus Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Aequus Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0382 | |||
| Maximum Drawdown | 150.0 |
Aequus Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aequus Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Aequus Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Aequus Pharmaceuticals historical prices to predict the future Aequus Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.7852 | |||
| Total Risk Alpha | 0.9976 | |||
| Treynor Ratio | (0.21) |
Aequus Pharmaceuticals Backtested Returns
Aequus Pharmaceuticals appears to be out of control, given 3 months investment horizon. Aequus Pharmaceuticals secures Sharpe Ratio (or Efficiency) of 0.0386, which signifies that the company had a 0.0386 % return per unit of risk over the last 3 months. By analyzing Aequus Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.83% is justified by implied risk. Please makes use of Aequus Pharmaceuticals' Risk Adjusted Performance of 0.0379, mean deviation of 6.5, and Standard Deviation of 21.39 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Aequus Pharmaceuticals holds a performance score of 3. The firm shows a Beta (market volatility) of -3.79, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Aequus Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Aequus Pharmaceuticals is expected to outperform it. Please check Aequus Pharmaceuticals' information ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to make a quick decision on whether Aequus Pharmaceuticals' price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Aequus Pharmaceuticals has no correlation between past and present. Overlapping area represents the amount of predictability between Aequus Pharmaceuticals time series from 28th of January 2025 to 12th of February 2025 and 12th of February 2025 to 27th of February 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Aequus Pharmaceuticals price movement. The serial correlation of 0.0 indicates that just 0.0% of current Aequus Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Aequus Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Aequus Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Aequus Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Aequus Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Aequus Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Aequus Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Aequus Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Aequus Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Aequus Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Aequus Pharmaceuticals Lagged Returns
When evaluating Aequus Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Aequus Pharmaceuticals stock have on its future price. Aequus Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Aequus Pharmaceuticals autocorrelation shows the relationship between Aequus Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Aequus Pharmaceuticals.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Aequus Stock Analysis
When running Aequus Pharmaceuticals' price analysis, check to measure Aequus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aequus Pharmaceuticals is operating at the current time. Most of Aequus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Aequus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aequus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Aequus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.